Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Conditions
Leukemia
Conditions: official terms
Leukemia - Leukemia, Myeloid - Leukemia, Myeloid, Acute
Conditions: Keywords
untreated adult acute myeloid leukemia, secondary acute myeloid leukemia, adult acute minimally differentiated myeloid leukemia (M0), adult acute myeloblastic leukemia without maturation (M1), adult acute myeloblastic leukemia with maturation (M2), adult acute myelomonocytic leukemia (M4), adult acute monoblastic leukemia (M5a), adult acute monocytic leukemia (M5b), adult erythroleukemia (M6a), adult pure erythroid leukemia (M6b), adult acute megakaryoblastic leukemia (M7), adult acute myeloid leukemia with 11q23 (MLL) abnormalities, adult acute myeloid leukemia with del(5q), adult acute myeloid leukemia with inv(16)(p13;q22), adult acute myeloid leukemia with t(16;16)(p13;q22), adult acute myeloid leukemia with t(8;21)(q22;q22)
Study Type
Interventional
Study Phase
Phase 3
Study Design
Allocation: Randomized, Masking: Open Label, Primary Purpose: Treatment
Intervention
Name: clofarabine Type: Drug
Name: cytarabine Type: Drug
Name: daunorubicin hydrochloride Type: Drug
Name: decitabine Type: Drug
Overall Status
Recruiting
Summary
RATIONALE: Drugs used in chemotherapy, such as clofarabine, daunorubicin hydrochloride, cytarabine, and decitabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. It is not yet known which chemotherapy regimen is more effective in treating acute myeloid leukemia.

PURPOSE: This randomized phase III trial is studying clofarabine to see how well it works compared with daunorubicin hydrochloride and cytarabine when followed by decitabine or observation in treating older patients with newly diagnosed acute myeloid leukemia.
Detailed Description
OBJECTIVES:

Primary

- To compare the overall survival of older patients with newly diagnosed acute myeloid leukemia (AML) treated with clofarabine as induction therapy and consolidation therapy vs standard daunorubicin hydrochloride and cytarabine.

Secondary

- To evaluate complete remission (CR) rates, duration of remission, and toxicity/treatment-related mortality of patients treated with these regimens.

- To evaluate the feasibility of consolidation therapy with reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation from HLA-identical donors, in terms of the incidence of successful engraftment, acute and chronic graft-vs-host disease, and transplant-related mortality in select patients age 60-69 years who achieve a response to induction therapy.

- To determine the impact of reduced-intensity conditioning and allogeneic stem cell transplantation on overall survival of select patients.

- To compare the duration of remission and disease-free survival of patients in CR following completion of consolidation therapy who are subsequently randomized to receive decitabine as maintenance therapy vs observation.

- To perform expression and methylation profiling in patients treated with decitabine as maintenance therapy and to correlate their integrated epigenetic signatures with response to decitabine.

- To examine the epigenetic profiles of remission marrow in patients randomized to receive decitabine as maintenance therapy vs observation to determine whether epigenetic signatures of apparently morphologically normal bone marrow is predictive of relapse or response to decitabine.

- To explore the possible association of response to clofarabine with nucleoside transporters hENT1, hCNT3, and ABC-transporter P-glycoprotein.

- To assess the intensity of expression of CXCR4 on diagnostic leukemia cells and to correlate this parameter with other established prognostic factors.

- To assess the entire spectrum of somatic mutations and affected pathways at diagnosis of AML and elucidate the association between gene mutation and outcome.

Tertiary

- To compare health-related quality of life (QOL) (physical, functional, leukemia-specific well-being) and fatigue in patients treated with clofarabine vs standard induction therapy.

- To measure the change in health-related QOL that occurs over time.

- To comprehensively assess patient function at the time of study enrollment.

- To determine if components of a comprehensive geriatric assessment or QOL scale predict ability to complete treatment for AML.

- To describe the impact of transplantation on QOL in patients with AML over 60 years of age.

OUTLINE: This is a multicenter study. Patients are stratified according to age (60-69 years vs ≥ 70 years), disease type (secondary vs de novo), therapy-related AML (yes vs no), and antecedent hematologic disorder (yes vs no).

- Induction therapy: Patients are randomized to 1 of 2 treatment arms.

- Arm I (standard therapy): Patients receive daunorubicin hydrochloride IV over 10-15 minutes on days 1-3 and cytarabine IV continuously on days 1-7. Patients with residual disease or those who do not achieve an aplastic bone marrow on day 12-14 (i.e., < 5% blasts and < 20% cellularity or markedly/moderately hypocellular) may receive a second course of induction therapy beginning no sooner than day 14.

- Arm II: Patients receive clofarabine IV over 1 hour on days 1-5. Patients with residual disease or those who do not achieve an aplastic bone marrow on day 12-14 (i.e., < 5% blasts and < 20% cellularity or markedly/moderately hypocellular) may receive a second course of induction therapy beginning no sooner than day 21 and no later than day 56.

Patients who achieve a complete remission (CR) or CR incomplete (CRi) after induction therapy proceed to consolidation therapy. Patients who are 60-69 years of age who achieve a "morphologic leukemia-free state" after induction therapy and who have an HLA-identical donor proceed to allogeneic stem cell transplantation. Patients undergoing second induction who do not achieve CR by day 56 of the start of re-induction are taken off protocol.

- Consolidation therapy: Beginning within 60 days after documentation of CR or CRi, patients receive consolidation therapy in the same arm they were randomized to for induction therapy.

- Arm I (standard therapy): Patients receive cytarabine IV over 1 hour once or twice daily on days 1-6. Treatment repeats every 4-6 weeks for 2 courses.

- Arm II: Patients receive clofarabine IV over 1 hour on days 1-5. Treatment repeats every 4-6 weeks for 2 courses.

Patients who remain in CR after completion of consolidation therapy proceed to maintenance therapy.

- Maintenance therapy: Beginning within 60 days after completion of consolidation therapy, patients receive maintenance therapy and are randomized to 1 of 2 arms.

- Arm I: Patients undergo observation monthly for 12 months.

- Arm II: Patients receive decitabine IV over 1 hour on days 1-3. Treatment repeats every 4 weeks for 12 months the absence of unacceptable toxicity.

- Allogeneic stem cell transplantation with reduced-intensity conditioning regimen: Patients begin reduced-intensity conditioning 30-90 days after the initiation of induction therapy.

- Conditioning regimen: Patients receive fludarabine phosphate IV over 30 minutes on days -7 to -3, busulfan IV over 2 hours every 6 hours on days -4 and -3 (for a total of 8 doses), and anti-thymocyte globulin IV over 4-6 hours on days -4 to -2.

- Transplantation: Patients undergo allogeneic peripheral blood stem cell transplantation on day 0.

Patients complete quality-of-life questionnaires periodically, including health-related quality of life, physical and functional well-being, and fatigue questionnaires.

Peripheral blood, bone marrow, and karyotype samples are collected periodically for cytogenetic analysis and other correlative laboratory studies.

After completion of study treatment, patients are followed up periodically for ≥ 5 years.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 60 Years
Gender: Both
Criteria: DISEASE CHARACTERISTICS:

- Newly diagnosed acute myeloid leukemia (AML)

- Considered candidates for intensive chemotherapy based on examination of peripheral blood or bone marrow aspirate specimens or touch preparations of the bone marrow biopsy obtained within the past 2 weeks

- Bone marrow aspirate is required for enrollment, however, if there is discordance between percentage of myeloblasts on the differential of the peripheral blood or aspirate, the peripheral blood criteria are sufficient for diagnosis

- Patients with secondary AML (defined as AML that has developed in a person with a history of antecedent blood count abnormalities, myelodysplastic syndromes [MDS], or a myeloproliferative disorder [excluding chronic myeloid leukemia], or a history of prior chemotherapy or radiotherapy for a disease other than AML) are eligible

- Patients with acute promyelocytic leukemia (APL) confirmed either by the presence of t(15;17)(q22;q21) or PML/RAR transcripts will be excluded

- No blastic transformation of chronic myelogenous leukemia

- No documented CNS involvement

- Concurrent registration on ECOG-E3903 (Ancillary Laboratory Protocol for the Collecting of Diagnostic Samples from Patients With Leukemia or Related Hematologic Disorders Being Considered for ECOG Treatment Clinical Trials) required (except for patients participating at CTSU institutions; these patients are exempt from this requirement)

- Cytogenetic analysis must be performed from diagnostic bone marrow (preferred) or if adequate number of circulating blasts (>10^9/L) from peripheral blood

- Diagnostic bone marrow and peripheral blood specimens must be submitted for immunophenotyping and selected molecular testing

- Peripheral blood stem cell donor meeting 1 of the following criteria:

- HLA-identical sibling (6/6)

- Low-resolution HLA typing (A,B,DR) allowed

- Matched unrelated donor (10/10)

- High-resolution class I and II typing (A,B,C,DRB1 and DQ) should be matched at all 10 loci

PATIENT CHARACTERISTICS:

- ECOG performance status (PS) 0-3 (ECOG PS 0-2 if ≥ 70 years of age)

- AST and ALT ≤ grade 1

- Total serum bilirubin ≤ 1.5 times upper limit of normal (ULN) (≤ grade 1)

- Serum creatinine ≤ 1 mg/dL (≤ grade 1)

- Cardiac ejection fraction ≥ 45% by MUGA or 2-D ECHO

- Fertile patients must use effective contraception

- No concurrent active malignancy requiring treatment (other than MDS)

- No active, uncontrolled infection

- No known HIV infection

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

- No prior chemotherapy for AML (except for hydroxyurea for increased blast count or leukapheresis for leukocytes)

- No prior treatment with azacitidine, decitabine, or low-dose cytarabine
Locations
UAB Comprehensive Cancer Center
Birmingham, Alabama, United States
Status: Recruiting
Contact: Clinical Trials Office - UAB Comprehensive Cancer Center - 205-934-0309
Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
Status: Recruiting
Contact: Clinical Trials Office - All Mayo Clinic Locations - 507-538-7623
Arizona Cancer Center at University Medical Center North
Tucson, Arizona, United States
Status: Recruiting
Contact: Faiz Anwer - 520-694-2873
Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, United States
Status: Recruiting
Contact: Clinical Trials Office - Arizona Cancer Center at University o - 520-626-9008
Aurora Presbyterian Hospital
Aurora, Colorado, United States
Status: Recruiting
Contact: Eduardo R. Pajon, MD - 303-399-8020ext2261
Boulder Community Hospital
Boulder, Colorado, United States
Status: Recruiting
Contact: Clinical Trials Office - Boulder Community Hospital - 303-938-5253
Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado, United States
Status: Recruiting
Contact: Clinical Trials Office - Penrose Cancer Center - 719-776-5275
CCOP - Colorado Cancer Research Program
Denver, Colorado, United States
Status: Recruiting
Contact: Eduardo R. Pajon, MD - 303-399-8020ext2261
Porter Adventist Hospital
Denver, Colorado, United States
Status: Recruiting
Contact: Eduardo R. Pajon, MD - 303-399-8020ext2261
Presbyterian - St. Luke's Medical Center
Denver, Colorado, United States
Status: Recruiting
Contact: Clinical Trials Office - Presbyterian - St. Luke's Medical Cen - 303-839-6000
Rose Medical Center
Denver, Colorado, United States
Status: Recruiting
Contact: Eduardo R. Pajon, MD - 303-399-8020ext2261
St. Anthony Central Hospital
Denver, Colorado, United States
Status: Recruiting
Contact: Eduardo R. Pajon, MD - 303-399-8020ext2261
St. Joseph Hospital
Denver, Colorado, United States
Status: Recruiting
Contact: Eduardo R. Pajon, MD - 303-399-8020ext2261
Swedish Medical Center
Englewood, Colorado, United States
Status: Recruiting
Contact: Eduardo R. Pajon, MD - 303-399-8020ext2261
North Colorado Medical Center
Greeley, Colorado, United States
Status: Recruiting
Contact: Eduardo R. Pajon, MD - 303-399-8020ext2261
Littleton Adventist Hospital
Littleton, Colorado, United States
Status: Recruiting
Contact: Eduardo R. Pajon, MD - 303-399-8020ext2261
Sky Ridge Medical Center
Lone Tree, Colorado, United States
Status: Recruiting
Contact: Eduardo R. Pajon, MD - 303-399-8020ext2261
Hope Cancer Care Center at Longmont United Hospital
Longmont, Colorado, United States
Status: Recruiting
Contact: Eduardo R. Pajon, MD - 303-399-8020ext2261
McKee Medical Center
Loveland, Colorado, United States
Status: Recruiting
Contact: Eduardo R. Pajon, MD - 303-399-8020ext2261
Parker Adventist Hospital
Parker, Colorado, United States
Status: Recruiting
Contact: Eduardo R. Pajon, MD - 303-399-8020ext2261
St. Mary - Corwin Regional Medical Center
Pueblo, Colorado, United States
Status: Recruiting
Contact: Eduardo R. Pajon, MD - 303-399-8020ext2261
North Suburban Medical Center
Thornton, Colorado, United States
Status: Recruiting
Contact: Eduardo R. Pajon, MD - 303-399-8020ext2261
Exempla Lutheran Medical Center
Wheat Ridge, Colorado, United States
Status: Recruiting
Contact: Clinical Trials Office - Exempla Lutheran Medical Center - 303-403-3605
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
Status: Recruiting
Contact: Christopher M. Reynolds - 860-714-4680
George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
New Britain, Connecticut, United States
Status: Recruiting
Contact: Clinical Trials Office - George Bray Cancer Center - 860-224-5660
Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
Status: Recruiting
Contact: Clinical Trials Office - Tunnell Cancer Center - 302-645-3171
CCOP - Christiana Care Health Services
Newark, Delaware, United States
Status: Recruiting
Contact: Clinical Trial Office - CCOP - Christiana Care Health Services - 302-623-4450
University of Florida Shands Cancer Center
Gainesville, Florida, United States
Status: Recruiting
Contact: Clinical Trials Office - University of Florida Shands Cancer C - 888-254-7581
Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
Status: Recruiting
Contact: Clinical Trials Office - All Mayo Clinic Locations - 507-538-7623
CCOP - Atlanta Regional
Atlanta, Georgia, United States
Status: Recruiting
Contact: Thomas E. Seay, MD, PhD - 404-851-2340
Northside Hospital Cancer Center
Atlanta, Georgia, United States
Status: Recruiting
Contact: Clinical Trials Office - Northside Hospital Cancer Center - 404-303-3355
Piedmont Hospital
Atlanta, Georgia, United States
Status: Recruiting
Contact: Thomas E. Seay, MD, PhD - 404-851-2340
Saint Joseph's Hospital of Atlanta
Atlanta, Georgia, United States
Status: Recruiting
Contact: Clinical Trials Office - Saint Joseph's Hospital of Atlanta - 404-851-7115
MBCCOP - Medical College of Georgia Cancer Center
Augusta, Georgia, United States
Status: Recruiting
Contact: Anand P. Jillella, MD - 706-721-2505
WellStar Cobb Hospital
Austell, Georgia, United States
Status: Recruiting
Contact: Clinical Trials Office - WellStar Cobb Hospital - 770-793-5980
John B. Amos Cancer Center
Columbus, Georgia, United States
Status: Recruiting
Contact: Clinical Trials Office - John B. Amos Cancer Center - 706-660-6404
Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur, Georgia, United States
Status: Recruiting
Contact: Thomas E. Seay, MD, PhD - 404-851-2340
Piedmont Fayette Hospital
Fayetteville, Georgia, United States
Status: Recruiting
Contact: Thomas E. Seay, MD, PhD - 404-851-2340
Gwinnett Medical Center
Lawrenceville, Georgia, United States
Status: Recruiting
Contact: Thomas E. Seay, MD, PhD - 404-851-2340
Kennestone Cancer Center at Wellstar Kennestone Hospital
Marietta, Georgia, United States
Status: Recruiting
Contact: Clinical Trials Office - Kennestone Cancer Center - 770-793-5980
Southern Regional Medical Center
Riverdale, Georgia, United States
Status: Recruiting
Contact: Clinical Trials Office - Southern Regional Medical Center - 770-991-8611
Harbin Clinic Cancer Center - Medical Oncology
Rome, Georgia, United States
Status: Recruiting
Contact: Thomas E. Seay, MD, PhD - 404-851-2340
Kapiolani Medical Center at Pali Momi
Aiea, Hawaii, United States
Status: Recruiting
Contact: Jeffrey L. Berenberg, MD - 808-433-4089
Oncare Hawaii, Incorporated - Pali Momi
Aiea, Hawaii, United States
Status: Recruiting
Contact: Jeffrey L. Berenberg, MD - 808-433-4089
Cancer Research Center of Hawaii
Honolulu, Hawaii, United States
Status: Recruiting
Contact: Clinical Trials Office - Cancer Research Center of Hawaii - 808-586-2979
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
Status: Recruiting
Contact: Jeffrey L. Berenberg, MD - 808-433-4089
Kuakini Medical Center
Honolulu, Hawaii, United States
Status: Recruiting
Contact: Jeffrey L. Berenberg, MD - 808-433-4089
OnCare Hawaii, Incorporated - Kuakini
Honolulu, Hawaii, United States
Status: Recruiting
Contact: Jeffrey L. Berenberg, MD - 808-433-4089
OnCare Hawaii, Incorporated - Lusitana
Honolulu, Hawaii, United States
Status: Recruiting
Contact: Jeffrey L. Berenberg, MD - 808-433-4089
Queen's Cancer Institute at Queen's Medical Center
Honolulu, Hawaii, United States
Status: Recruiting
Contact: Jeffrey L. Berenberg, MD - 808-433-4089
Straub Clinic and Hospital, Incorporated
Honolulu, Hawaii, United States
Status: Recruiting
Contact: Jeffrey L. Berenberg, MD - 808-433-4089
Castle Medical Center
Kailua, Hawaii, United States
Status: Recruiting
Contact: Jeffrey L. Berenberg, MD - 808-433-4089
Kauai Medical Clinic
Lihue, Hawaii, United States
Status: Recruiting
Contact: Jeffrey L. Berenberg, MD - 808-433-4089
Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
Boise, Idaho, United States
Status: Recruiting
Contact: Clinical Trials Office - Saint Alphonsus Cancer Care Center - 208-367-7954
Illinois CancerCare - Bloomington
Bloomington%, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-662-2102
St. Joseph Medical Center
Bloomington, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-662-3311
Graham Hospital
Canton, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-647-5240
Illinois CancerCare - Canton
Canton, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-647-5240
Illinois CancerCare - Carthage
Carthage, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 217-357-6877
Memorial Hospital
Carthage, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 217-357-3131
Hematology and Oncology Associates
Chicago, Illinois, United States
Status: Recruiting
Contact: Clinical Trails Office - Hematology and Oncology Associates - 312-695-1301
Mount Sinai Hospital Medical Center
Chicago, Illinois, United States
Status: Recruiting
Contact: Pam G. Khosla, MD - 773-542-2000
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
Status: Recruiting
Contact: Clinical Trials Office - Robert H. Lurie Comprehensive Cancer - 312-695-1301 - cancer@northwestern.edu
Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, United States
Status: Recruiting
Contact: Clinical Trials Office - Decatur Memorial Hospital Cancer Care - 217-876-4750
Eureka Community Hospital
Eureka, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-467-2371
Illinois CancerCare - Eureka
Eureka, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-467-2371
Galesburg Clinic, PC
Galesburg, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-344-1000
Illinois CancerCare - Havana
Havana, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-543-8557
Kellogg Cancer Care Center
Highland Park, Illinois, United States
Status: Recruiting
Contact: Jessica K. Altman - 847-480-3800
Hinsdale Hematology Oncology Associates
Hinsdale, Illinois, United States
Status: Recruiting
Contact: Elyse C. Schneiderman, MD - 630-654-1790
Provena St. Mary's Regional Cancer Center - Kankakee
Kankakee, Illinois, United States
Status: Recruiting
Contact: Jessica K. Altman - 815-937-8780
Illinois CancerCare - Kewanee Clinic
Kewanee, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-852-0598
North Shore Oncology and Hematology Associates, Limited - Libertyville
Libertyville, Illinois, United States
Status: Recruiting
Contact: Jessica K. Altman - 847-367-6781
Illinois CancerCare - Macomb
Macomb, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-833-3503
McDonough District Hospital
Macomb, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-833-4101
Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, United States
Status: Recruiting
Contact: Clinical Trials Office - Cardinal Bernardin Cancer Center - 708-226-4357
Illinois CancerCare - Monmouth
Monmouth, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-734-3141
OSF Holy Family Medical Center
Monmouth, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-734-3141
Good Samaritan Regional Health Center
Mount Vernon, Illinois, United States
Status: Recruiting
Contact: Bethany G. Sleckman, MD - 314-251-7057
Cancer Care and Hematology Specialists of Chicagoland - Niles
Niles, Illinois, United States
Status: Recruiting
Contact: Jessica K. Altman - 847-827-9060
BroMenn Regional Medical Center
Normal, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-454-1400
Community Cancer Center
Normal, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-451-8500
Illinois CancerCare - Community Cancer Center
Normal, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-662-2102
Community Hospital of Ottawa
Ottawa, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 815-433-3100
Oncology Hematology Associates of Central Illinois, PC - Ottawa
Ottawa, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 815-431-9270
Cancer Treatment Center at Pekin Hospital
Pekin, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-353-0512
Illinois CancerCare - Pekin
Pekin, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-353-0214
CCOP - Illinois Oncology Research Association
Peoria, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-243-3605
Methodist Medical Center of Illinois
Peoria, Illinois, United States
Status: Recruiting
Contact: Clinical Trials Office - Methodist Medical Center of Illinois - 309-243-3000
Oncology Hematology Associates of Central Illinois, PC - Peoria
Peoria, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-243-3000
OSF St. Francis Medical Center
Peoria, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-655-2000
Proctor Hospital
Peoria, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 309-691-1000
Illinois CancerCare - Peru
Peru, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 815-780-3185
Illinois Valley Community Hospital
Peru, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 815-223-3000
Illinois CancerCare - Princeton
Princeton, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 815-875-3010
Swedish-American Regional Cancer Center
Rockford, Illinois, United States
Status: Recruiting
Contact: Clinical Trials Office - Swedish-American Regional Cancer Cent - 815-489-4413
Hematology Oncology Associates - Skokie
Skokie, Illinois, United States
Status: Recruiting
Contact: Jessica K. Altman - 847-568-9930
Illinois CancerCare - Spring Valley
Spring Valley, Illinois, United States
Status: Recruiting
Contact: Nguyet A. Le-Lindqwister - 815-664-1487
Regional Cancer Center at Memorial Medical Center
Springfield, Illinois, United States
Status: Recruiting
Contact: Clinical Trials Office - Regional Cancer Center at Memorial Me - 217-788-4233
St. Francis Hospital and Health Centers - Beech Grove Campus
Beech Grove, Indiana, United States
Status: Recruiting
Contact: Howard M. Gross, MD - 937-832-1093
Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana, United States
Status: Recruiting
Contact: Sreenivasa R. Nattam, MD - 260-484-8830
Reid Hospital & Health Care Services
Richmond, Indiana, United States
Status: Recruiting
Contact: Howard M. Gross, MD - 937-832-1093
McFarland Clinic, PC
Ames, Iowa, United States
Status: Recruiting
Contact: Clinical Trials Office - McFarland Clinic, PC - 515-239-2621
Mercy Medical Center - Sioux City
Sioux City, Iowa, United States
Status: Recruiting
Contact: Donald B. Wender, MD, PhD - 712-252-0088
Siouxland Hematology-Oncology Associates, LLP
Sioux City, Iowa, United States
Status: Recruiting
Contact: Donald B. Wender, MD, PhD - 712-252-0088
St. Luke's Regional Medical Center
Sioux City, Iowa, United States
Status: Recruiting
Contact: Donald B. Wender, MD, PhD - 712-252-0088
Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky, United States
Status: Recruiting
Contact: Clinical Trials Office - Markey Cancer Center at University of - 859-257-3379
Harold Alfond Center for Cancer Care
Augusta, Maine, United States
Status: Recruiting
Contact: Thomas H. Openshaw - 207-621-6100
CancerCare of Maine at Eastern Maine Medical Center
Bangor, Maine, United States
Status: Recruiting
Contact: Clinical Trials Office - CancerCare of Maine - 207-973-4274
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
Status: Recruiting
Contact: Clinical Trials Office - Sidney Kimmel Comprehensive Cancer Ce - 410-955-8804 - jhcccro@jhmi.edu
National Naval Medical Center
Bethesda, Maryland, United States
Status: Recruiting
Contact: David C. Van Echo - 301-295-5706
Union Hospital of Cecil County
Elkton MD, Maryland, United States
Status: Recruiting
Contact: Frank Beardell, MD - 302-737-7700
Tufts Medical Center Cancer Center
Boston, Massachusetts, United States
Status: Recruiting
Contact: Kellie A. Sprague - 617-636-6100
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, Massachusetts, United States
Status: Recruiting
Contact: Syed S. Ali - 413-794-9338
CCOP - Michigan Cancer Research Consortium
Ann Arbor, Michigan, United States
Status: Recruiting
Contact: Christopher M. Reynolds - 877-590-5995
Saint Joseph Mercy Cancer Center
Ann Arbor, Michigan, United States
Status: Recruiting
Contact: Christopher M. Reynolds - 734-712-5658
Battle Creek Health System Cancer Care Center
Battle Creek, Michigan, United States
Status: Recruiting
Contact: Gilbert D.A. Padula - 616-966-8000
Mecosta County Medical Center
Big Rapids, Michigan, United States
Status: Recruiting
Contact: Gilbert D.A. Padula - 231-796-8691
Oakwood Cancer Center at Oakwood Hospital and Medical Center
Dearborn, Michigan, United States
Status: Recruiting
Contact: Clinical Trials Office - Oakwood Cancer Center at Oakwood Hosp - 313-593-8090
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
Status: Recruiting
Contact: Clinical Trials Office - Barbara Ann Karmanos Cancer Institute - 313-576-9363
Genesys Hurley Cancer Institute
Flint, Michigan, United States
Status: Recruiting
Contact: Clinical Trials Office - Genesys Hurley Cancer Institute - 810-762-8057
Hurley Medical Center
Flint, Michigan, United States
Status: Recruiting
Contact: Clinical Trials Office - Hurley Medical Center - 810-762-8057
Genesys Regional Medical Center
Grand Blanc, Michigan, United States
Status: Recruiting
Contact: Christopher M. Reynolds - 810-606-5000
Butterworth Hospital at Spectrum Health
Grand Rapids, Michigan, United States
Status: Recruiting
Contact: Gilbert D.A. Padula - 616-391-2799
CCOP - Grand Rapids
Grand Rapids, Michigan, United States
Status: Recruiting
Contact: Gilbert D.A. Padula - 616-391-1230
Lacks Cancer Center at Saint Mary's Health Care
Grand Rapids, Michigan, United States
Status: Recruiting
Contact: Gilbert D.A. Padula - 616-752-5222
Van Elslander Cancer Center at St. John Hospital and Medical Center
Grosse Pointe Woods, Michigan, United States
Status: Recruiting
Contact: Clincial Trials Office - Van Elslander Cancer Center at St. Jo - 313-343-3166
Foote Memorial Hospital
Jackson, Michigan, United States
Status: Recruiting
Contact: Christopher M. Reynolds - 517-788-4800
Borgess Medical Center
Kalamazoo, Michigan, United States
Status: Recruiting
Contact: Raymond S. Lord, MD - 269-373-7458
Bronson Methodist Hospital
Kalamazoo, Michigan, United States
Status: Recruiting
Contact: Raymond S. Lord, MD - 269-373-7458
West Michigan Cancer Center
Kalamazoo, Michigan, United States
Status: Recruiting
Contact: Clinical Trials Office - West Michigan Cancer Center - 269-373-7458
Sparrow Regional Cancer Center
Lansing, Michigan, United States
Status: Recruiting
Contact: Clinical Trials Office - Sparrow Regional Cancer Center - 517-364-2890
St. Mary Mercy Hospital
Livonia, Michigan, United States
Status: Recruiting
Contact: Christopher M. Reynolds - 734-464-4800
Mercy General Health Partners
Muskegon, Michigan, United States
Status: Recruiting
Contact: Gilbert D.A. Padula - 231-672-2000
St. Joseph Mercy Oakland
Pontiac, Michigan, United States
Status: Recruiting
Contact: Christopher M. Reynolds - 248-858-3612
Mercy Regional Cancer Center at Mercy Hospital
Port Huron, Michigan, United States
Status: Recruiting
Contact: Christopher M. Reynolds - 810-985-1484
Spectrum Health Reed City Hospital
Reed City, Michigan, United States
Status: Recruiting
Contact: Gilbert D.A. Padula - 231-832-3271
Seton Cancer Institute at Saint Mary's - Saginaw
Saginaw, Michigan, United States
Status: Recruiting
Contact: Clinical Trials Office - Seton Cancer Institute - Saginaw - 989-776-8411
Providence Cancer Institute at Providence Hospital - Southfield Campus
Southfield, Michigan, United States
Status: Recruiting
Contact: Howard R. Terebelo, DO - 248-552-0620
Munson Medical Center
Traverse City, Michigan, United States
Status: Recruiting
Contact: Gilbert D.A. Padula - 231-935-6202
St. John Macomb Hospital
Warren, Michigan, United States
Status: Recruiting
Contact: Christopher M. Reynolds - 586-573-5757
MeritCare Bemidji
Bemidji, Minnesota, United States
Status: Recruiting
Contact: Preston D. Steen, MD - 701-234-2397
CCOP - Duluth
Duluth, Minnesota, United States
Status: Recruiting
Contact: Daniel Nikcevich, MD, PhD - 218-786-3625
Duluth Clinic Cancer Center - Duluth
Duluth, Minnesota, United States
Status: Recruiting
Contact: Clinical Trials Office - Duluth Clinic Cancer Center - Duluth - 218-786-3308
Miller - Dwan Medical Center
Duluth, Minnesota, United States
Status: Recruiting
Contact: Daniel Nikcevich, MD, PhD - 218-786-3625
Mayo Clinic Cancer Center
Rochester, Minnesota, United States
Status: Recruiting
Contact: Clinical Trials Office - All Mayo Clinic Locations - 507-538-7623
Saint Francis Medical Center
Cape Girardeau, Missouri, United States
Status: Recruiting
Contact: Bethany G. Sleckman, MD - 314-251-7057
CCOP - St. Louis-Cape Girardeau
Saint Louis, Missouri, United States
Status: Recruiting
Contact: Bethany G. Sleckman, MD - 314-251-7057
David C. Pratt Cancer Center at St. John's Mercy
Saint Louis, Missouri, United States
Status: Recruiting
Contact: Clinical Trials Office - David C. Pratt Cancer Center at St. J - 314-251-6770
Midwest Hematology Oncology Group, Incorporated
Saint Louis, Missouri, United States
Status: Recruiting
Contact: Bethany G. Sleckman, MD - 314-251-7057
Saint Louis University Cancer Center
Saint Louis, Missouri, United States
Status: Recruiting
Contact: Clinical Trials Office - Saint Louis University Cancer Center - 314-977-4440
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
Saint Louis, Missouri, United States
Status: Recruiting
Contact: Geoffrey L. Uy - 314-747-7222
Billings Clinic - Downtown
Billings, Montana, United States
Status: Recruiting
Contact: Clinical Trials Office - Billings Clinic - Downtown - 800-996-2663 - research@billingsclinic.org
CCOP - Montana Cancer Consortium
Billings, Montana, United States
Status: Recruiting
Contact: Benjamin T. Marchello, MD - 406-238-6290
Hematology-Oncology Centers of the Northern Rockies - Billings
Billings, Montana, United States
Status: Recruiting
Contact: Benjamin T. Marchello, MD - 406-238-6290
St. Vincent Healthcare Cancer Care Services
Billings, Montana, United States
Status: Recruiting
Contact: Benjamin T. Marchello, MD - 406-238-6290
Bozeman Deaconess Cancer Center
Bozeman, Montana, United States
Status: Recruiting
Contact: Benjamin T. Marchello, MD - 406-238-6290
St. James Healthcare Cancer Care
Butte, Montana, United States
Status: Recruiting
Contact: Benjamin T. Marchello, MD - 406-238-6290
Great Falls Clinic - Main Facility
Great Falls, Montana, United States
Status: Recruiting
Contact: Benjamin T. Marchello, MD - 406-238-6290
Sletten Cancer Institute at Benefis Healthcare
Great Falls, Montana, United States
Status: Recruiting
Contact: Benjamin T. Marchello, MD - 406-238-6290
St. Peter's Hospital
Helena, Montana, United States
Status: Recruiting
Contact: Benjamin T. Marchello, MD - 406-238-6290
Glacier Oncology, PLLC
Kalispell, Montana, United States
Status: Recruiting
Contact: Benjamin T. Marchello, MD - 406-238-6290
Kalispell Medical Oncology at KRMC
Kalispell, Montana, United States
Status: Recruiting
Contact: Benjamin T. Marchello, MD - 406-238-6290
Kalispell Regional Medical Center
Kalispell, Montana, United States
Status: Recruiting
Contact: Benjamin T. Marchello, MD - 406-238-6290
Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
Missoula, Montana, United States
Status: Recruiting
Contact: Clinical Trials Office - Montana Cancer Center at St. Patrick - 406-329-7029
Montana Cancer Specialists at Montana Cancer Center
Missoula, Montana, United States
Status: Recruiting
Contact: Clinical Trials Office - Montana Cancer Specialists at Montana - 406-238-6962
CCOP - Nevada Cancer Research Foundation
Las Vegas, Nevada, United States
Status: Recruiting
Contact: John A. Ellerton, MD, CM - 702-384-0013
Cancer Institute of New Jersey at Cooper - Voorhees
Voorhees, New Jersey, United States
Status: Recruiting
Contact: Clinical Trials Office - Cancer Institute of New Jersey at Coo - 856-325-6757
Winthrop University Hospital
Mineola, New York, United States
Status: Recruiting
Contact: Harry Staszewski, MD - 516-663-9500
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Status: Recruiting
Contact: Martin S. Tallman, MD - 312-695-0990
James P. Wilmot Cancer Center at University of Rochester Medical Center
Rochester, New York, United States
Status: Recruiting
Contact: Jonathan W. Friedberg - 585-275-5345
Kinston Medical Specialists
Kinston, North Carolina, United States
Status: Recruiting
Contact: Peter R. Watson, MD - 252-559-2200ext.201
CCOP - MeritCare Hospital
Fargo, North Dakota, United States
Status: Recruiting
Contact: Preston D. Steen, MD - 701-234-2397
MeritCare Broadway
Fargo, North Dakota, United States
Status: Recruiting
Contact: Preston D. Steen, MD - 701-234-2397
Roger Maris Cancer Center at MeritCare Hospital
Fargo, North Dakota, United States
Status: Recruiting
Contact: Preston D. Steen, MD - 701-234-2397
Summa Center for Cancer Care at Akron City Hospital
Akron, Ohio, United States
Status: Recruiting
Contact: Clinical Trials Office - Akron City Hospital - 330-375-6101
Barberton Citizens Hospital
Barberton, Ohio, United States
Status: Recruiting
Contact: Jennifer E. Payne - 330-745-1611
Aultman Cancer Center at Aultman Hospital
Canton, Ohio, United States
Status: Recruiting
Contact: Clinical Trials Office - Aultman Cancer Center at Aultman Hosp - 330-363-6891
Jewish Hospital Cancer Center
Cincinnati, Ohio, United States
Status: Recruiting
Contact: E. Randolph Broun, MD - 513-686-5482
Case Comprehensive Cancer Center
Cleveland, Ohio, United States
Status: Recruiting
Contact: Clinical Trials Office - Case Comprehensive Cancer Center - 800-641-2422
MetroHealth Cancer Care Center at MetroHealth Medical Center
Cleveland, Ohio, United States
Status: Recruiting
Contact: Bruce J. Averbook, MD, FACS - 216-778-4795
CCOP - Dayton
Dayton, Ohio, United States
Status: Recruiting
Contact: Howard M. Gross, MD - 937-832-1093
David L. Rike Cancer Center at Miami Valley Hospital
Dayton, Ohio, United States
Status: Recruiting
Contact: Clinical Trials Office - David L. Rike Cancer Center at Miami - 937-208-2079
Good Samaritan Hospital
Dayton, Ohio, United States
Status: Recruiting
Contact: Howard M. Gross, MD - 937-832-1093
Grandview Hospital
Dayton, Ohio, United States
Status: Recruiting
Contact: Howard M. Gross, MD - 937-832-1093
Samaritan North Cancer Care Center
Dayton, Ohio, United States
Status: Recruiting
Contact: Howard M. Gross, MD - 937-832-1093
Blanchard Valley Medical Associates
Findlay, Ohio, United States
Status: Recruiting
Contact: Howard M. Gross, MD - 937-832-1093
Middletown Regional Hospital
Franklin, Ohio, United States
Status: Recruiting
Contact: Howard M. Gross, MD - 937-832-1093
Wayne Hospital
Greenville, Ohio, United States
Status: Recruiting
Contact: Howard M. Gross, MD - 937-832-1093
Charles F. Kettering Memorial Hospital
Kettering, Ohio, United States
Status: Recruiting
Contact: Clinical Trials Office - Charles F. Kettering Memorial Hospita - 937-298-3399 ext. 57556
St. Rita's Medical Center
Lima, Ohio, United States
Status: Recruiting
Contact: Clinical Trials Office - St. Rita's Medical Center - 419-226-9617
UVMC Cancer Care Center at Upper Valley Medical Center
Troy, Ohio, United States
Status: Recruiting
Contact: Clinical Trials Office - UVMC Cancer Care Center at Upper Vall - 937-440-4842
Ruth G. McMillan Cancer Center at Greene Memorial Hospital
Xenia, Ohio, United States
Status: Recruiting
Contact: Howard M. Gross, MD - 937-832-1093
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma, United States
Status: Recruiting
Contact: Shubham Pant - 405-271-6822
Clackamas Radiation Oncology Center
Clackamas, Oregon, United States
Status: Recruiting
Contact: Alison K. Conlin - 503-513-3300
Providence Milwaukie Hospital
Milwaukie, Oregon, United States
Status: Recruiting
Contact: Alison K. Conlin - 503-513-8300
Providence Newberg Medical Center
Newberg, Oregon, United States
Status: Recruiting
Contact: Alison K. Conlin - 503-537-1555
Willamette Falls Hospital
Oregon City, Oregon, United States
Status: Recruiting
Contact: Alison K. Conlin - 503-650-6758
CCOP - Columbia River Oncology Program
Portland, Oregon, United States
Status: Recruiting
Contact: Alison K. Conlin - 503-216-6260
Providence Cancer Center at Providence Portland Medical Center
Portland, Oregon, United States
Status: Recruiting
Contact: Clinical Trials Office - Providence Cancer Center at Providenc - 503-215-6412
Providence St. Vincent Medical Center
Portland, Oregon, United States
Status: Recruiting
Contact: Clinical Trials Office - Providence St. Vincent Medical Center - 503-215-6412
Geisinger Cancer Institute at Geisinger Health
Danville, Pennsylvania, United States
Status: Recruiting
Contact: Clinical Trials Office - Geisinger Cancer Institute - 570-271-5251
Geisinger Hazleton Cancer Center
Hazleton, Pennsylvania, United States
Status: Recruiting
Contact: Edward J. Gorak, II - 570-459-2901
Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
Status: Recruiting
Contact: Clinical Trials Office - Penn State Hershey Cancer Institute a - 717-531-3779 - CTO@hmc.psu.edu
Lewistown Hospital
Lewistown, Pennsylvania, United States
Status: Recruiting
Contact: David F. Claxton - 717-242-7143
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Status: Recruiting
Contact: Clinical Trials Office - Abramson Cancer Center of the Univers - 800-474-9892
Joan Karnell Cancer Center at Pennsylvania Hospital
Philadelphia, Pennsylvania, United States
Status: Recruiting
Contact: Lee Hartner - 215-829-3000
Hematology and Oncology Associates of Northeastern Pennsylvania
Scranton, Pennsylvania, United States
Status: Recruiting
Contact: Andrew E. Chapman - 570-342-3675
Geisinger Medical Group - Scenery Park
State College, Pennsylvania, United States
Status: Recruiting
Contact: Edward J. Gorak, II - 814-231-4560
Mount Nittany Medical Center
State College, Pennsylvania, United States
Status: Recruiting
Contact: David F. Claxton - 814-231-7000
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
Wilkes-Barre, Pennsylvania, United States
Status: Recruiting
Contact: Clinical Trials Office - Frank M. and Dorothea Henry Cancer Ce - 570-271-5251
York Cancer Center at Apple Hill Medical Center
York, Pennsylvania, United States
Status: Recruiting
Contact: Amir Tabatabai, MD - 717-741-9229
Sanford Cancer Center at Sanford USD Medical Center
Sioux Falls, South Dakota, United States
Status: Recruiting
Contact: Clinical Trials Office - Sanford Cancer Center - 605-328-1367
Erlanger Cancer Center at Erlanger Hospital - Baroness
Chattanooga, Tennessee, United States
Status: Recruiting
Contact: Clinical Trials Office - Erlanger Cancer Center - 423-778-6947
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
Status: Recruiting
Contact: Clinical Trials Office - Vanderbilt-Ingram Cancer Center - 800-811-8480
Northwest Cancer Specialists at Vancouver Cancer Center
Vancouver, Washington, United States
Status: Recruiting
Contact: Alison K. Conlin - 360-944-9889
Southwest Washington Medical Center Cancer Center
Vancouver, Washington, United States
Status: Recruiting
Contact: Alison K. Conlin - 360-514-2174
West Virginia University Health Sciences Center - Charleston
Charleston, West Virginia, United States
Status: Recruiting
Contact: Steven J. Jubelirer, MD - 304-388-8380
Mary Babb Randolph Cancer Center at West Virginia University Hospitals
Morgantown, West Virginia, United States
Status: Recruiting
Contact: Michael D. Craig - 304-293-4500
Green Bay Oncology, Limited at St. Mary's Hospital
Green Bay, Wisconsin, United States
Status: Recruiting
Contact: Gerald K. Bayer, MD - 920-432-6049
Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
Green Bay, Wisconsin, United States
Status: Recruiting
Contact: Gerald K. Bayer, MD - 920-432-6049
St. Mary's Hospital Medical Center - Green Bay
Green Bay, Wisconsin, United States
Status: Recruiting
Contact: Gerald K. Bayer, MD - 920-432-6049
St. Vincent Hospital Regional Cancer Center
Green Bay, Wisconsin, United States
Status: Recruiting
Contact: Clinical Trials Office - St. Vincent Hospital Regional Cancer - 920-433-8889
Gundersen Lutheran Center for Cancer and Blood
La Crosse, Wisconsin, United States
Status: Recruiting
Contact: Clinical Trials Office - Gundersen Lutheran Cancer Center - 608-775-2385 - cancerctr@gundluth.org
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
Madison, Wisconsin, United States
Status: Recruiting
Contact: Clinical Trials Office - University of Wisconsin Paul P. Carbo - 608-262-5223
Holy Family Memorial Medical Center Cancer Care Center
Manitowoc, Wisconsin, United States
Status: Recruiting
Contact: Clinical Trials Office - Holy Family Memorial Medical Center C - 920-320-2749
Bay Area Cancer Care Center at Bay Area Medical Center
Marinette, Wisconsin, United States
Status: Recruiting
Contact: Gerald K. Bayer, MD - 920-432-6049
Medical College of Wisconsin Cancer Center
Milwaukee, Wisconsin, United States
Status: Recruiting
Contact: Clinical Trials Office - Medical College of Wisconsin Cancer C - 414-805-4380
D.N. Greenwald Center
Mukwonago, Wisconsin, United States
Status: Recruiting
Contact: Michael A. Thompson - 262-363-1916
Regional Cancer Center at Oconomowoc Memorial Hospital
Oconomowoc, Wisconsin, United States
Status: Recruiting
Contact: Clinical Trials Office - Regional Cancer Center at Oconomowoc - 262-928-7878
St. Nicholas Hospital
Sheboygan, Wisconsin, United States
Status: Recruiting
Contact: Gerald K. Bayer, MD - 920-432-6049
Waukesha Memorial Hospital Regional Cancer Center
Waukesha, Wisconsin, United States
Status: Recruiting
Contact: Clinical Trials Office - Waukesha Memorial Hospital Regional C - 262-928-7632
Rocky Mountain Oncology
Casper, Wyoming, United States
Status: Recruiting
Contact: Benjamin T. Marchello, MD - 406-238-6290
Rambam Medical Center
Haifa, Israel
Status: Recruiting
Contact: Jacob M. Rowe, MD - 972-4-854-2541
Shaare Zedek Medical Center
Jerusalem, Israel
Status: Recruiting
Contact: Jacob M. Rowe, MD - 972-4-854-2541
Start Date
January 2011
Sponsors
Eastern Cooperative Oncology Group
Source
Eastern Cooperative Oncology Group
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page